John M. Dunn

John Dunn has over 25 years of experience practicing corporate law in the life science industry. Mr. Dunn serves on the Boards of Acer Therapeutics, a publicly traded pharmaceutical company, Sharp Healthcare, a San Diego not-for-profit healthcare system, and Biocom and Connect, non-profit organizations supporting the life science and technology industries in the San Diego area. Over the last 15 years Mr. Dunn has also served as a senior advisor to TVM Capital, a life science venture capital firm.

Mr. Dunn recently served as General Counsel and Secretary of Vital Therapies, Inc., a public biotech company, until its merger with Immunic, Inc. Previously, he spent 10 years at Biogen Idec where he was an Executive Vice President and the head of their corporate venture group, which made and managed strategic investments in emerging biotech companies. Prior to the merger of IDEC Pharmaceuticals and Biogen, Mr. Dunn served on the senior management team as Senior Vice President and General Counsel of IDEC where he led its legal and compliance departments. Mr. Dunn was a partner at the law firm of Pillsbury Winthrop Shaw Pitman. He earned a B.S. in finance and a J.D. from the University of Wyoming.